PHARMA REVIEW SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

27/03/2014

VAT status

Active

Bankruptcy proceedings

No proceedings

PHARMA REVIEW SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated because the company delayed submission of financial statements.

Incorporation date

19/09/2014

Share capital

5,000.00 PLN

Primary activity

Other out-of-school forms of education, not elsewhere classified (85.59.B - PKD 2007)

Representatives

Representatives rights

KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIE

Representatives

Chairman of the management boardA**** B****** K****-W******

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
A** B** K-W****	Chairman of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

-174,667

Net Profit (zł)

-174,667

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2021
474,913
-
-9,432
2.72
-
-1.99
1,217,441
0
0
813

2022
196,577
-
-174,667
6.36
-
-88.85
1,042,774
0
0
2,647

2022
196,577
-
-174,667
6.36
-
-88.85
1,042,774
0
0
2,647

Turnover (zł)

2022

Turnover (zł)

196,577 zł-59 % *

Profit before tax (zł)

Net Profit (zł)

-174,667 zł-1,752 % *

Working capital requirement (%)

6.36 133.82 % *

Liquidity ratio

Net profitability (%)

-88.85 %-4,364.82 % *

Equity (zł)

1,042,774 zł-14 % *

Current liabilities (zł)

0 zł- *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

2,647 zł226 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

PHARMA REVIEW SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
01/08/2023	OD 01.01.2021 DO 31.12.2021
01/08/2023	OD 01.01.2022 DO 31.12.2022
04/05/2022	OD 01.01.2020 DO 31.12.2020
29/12/2020	OD 01.01.2018 DO 31.12.2018
29/12/2020	OD 01.01.2019 DO 31.12.2019